Cost-effectiveness of Dapagliflozin in Heart Failure With Reduced Ejection Fraction

被引：0
|
作者：
Isaza, Nicolas
Calvachi, Paola
Raber, Inbar
Shen, Changyu
Gavin, Michael C.
Garan, A. Reshad
Bellows, Brandon K.
Kazi, Dhruv S.
机构：
来源：
CIRCULATION | 2020年 / 142卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A15981
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Dapagliflozin in patients with heart failure and reduced ejection fraction
    Giorgio Colombo
    Rosa Casella
    Alessia Cazzaniga
    Chiara Casiraghi
    [J]. Internal and Emergency Medicine, 2020, 15 : 515 - 517
  • [32] Dapagliflozin in patients with heart failure and reduced ejection fraction
    Colombo, Giorgio
    Casella, Rosa
    Cazzaniga, Alessia
    Casiraghi, Chiara
    [J]. INTERNAL AND EMERGENCY MEDICINE, 2020, 15 (03) : 515 - 517
  • [33] Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
    McMurray, J. J. V.
    Solomon, S. D.
    Inzucchi, S. E.
    Kober, L.
    Kosiborod, M. N.
    Martinez, F. A.
    Ponikowski, P.
    Sabatine, M. S.
    Anand, I. S.
    Belohlavek, J.
    Bohm, M.
    Chiang, C. -E.
    Chopra, V. K.
    de Boer, R. A.
    Desai, A. S.
    Diez, M.
    Drozdz, J.
    Dukat, A.
    Ge, J.
    Howlett, J. G.
    Katova, T.
    Kitakaze, M.
    Ljungman, C. E. A.
    Merkely, B.
    Nicolau, J. C.
    O'Meara, E.
    Petrie, M. C.
    Vinh, P. N.
    Schou, M.
    Tereshchenko, S.
    Verma, S.
    Held, C.
    DeMets, D. L.
    Docherty, K. F.
    Jhund, P. S.
    Bengtsson, O.
    Sjostrand, M.
    Langkilde, A. -M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (21): : 1995 - 2008
  • [34] Dapagliflozin for patients with heart failure and reduced ejection fraction
    Ferry, Abigail
    [J]. JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2022, 35 (09): : 51 - 53
  • [35] Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
    Vieira, Jefferson L.
    Mehra, Mandeep R.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (10): : 972 - 973
  • [36] The cost-effectiveness of dapagliflozin in heart failure with preserved or mildly reduced ejection fraction: a European health-economic analysis of the DELIVER trial
    Booth, David
    Davis, Jason A.
    McEwan, Phil
    Solomon, Scott D.
    McMurray, John J. V.
    De Boer, Rudolf A.
    Comin-Colet, Josep
    Bachus, Erasmus
    Chen, Jieling
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 (08) : 1386 - 1395
  • [37] Cost-effectiveness of dapagliflozin as a treatment for heart failure with reduced ejection fraction: a multinational health-economic analysis ofDAPA-HF
    McEwan, Phil
    Darlington, Oliver
    McMurray, John J. V.
    Jhund, Pardeep S.
    Docherty, Kieran F.
    Boehm, Michael
    Petrie, Mark C.
    Bergenheim, Klas
    Qin, Lei
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 (11) : 2147 - 2156
  • [38] Cost-effectiveness evaluation of add-on dapagliflozin for heart failure with reduced ejection fraction among patients without type 2 diabetes
    Al-Badriyeh, Daoud
    Abushanab, Dina
    Chbib, Salma
    Kaddoura, Rasha
    Al Hail, Moza
    Rouf, Pallivalapilla Abdul
    El-Kassem, Wessam
    Shah, Jassim Zaheen
    Nair, Ramesh
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 396 - 397
  • [39] Cost Effectiveness of Adding Dapagliflozin to Standard Care in Heart Failure Patients with Reduced Ejection Fraction: A Systematic Review
    Rezapour, Aziz
    Tashakori-Miyanroudi, Mahsa
    Haghjoo, Majid
    Barzegar, Mohammad
    Tatarpour, Parvin
    Souresrafil, Aghdas
    Gorji, Hassan Abolghasem
    Yousefzadeh, Negar
    Sheikhy-Chaman, Mohammadreza
    [J]. AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2023, 23 (02) : 127 - 144
  • [40] Cost Effectiveness of Adding Dapagliflozin to Standard Care in Heart Failure Patients with Reduced Ejection Fraction: A Systematic Review
    Aziz Rezapour
    Mahsa Tashakori-Miyanroudi
    Majid Haghjoo
    Mohammad Barzegar
    Parvin Tatarpour
    Aghdas Souresrafil
    Hassan Abolghasem Gorji
    Negar Yousefzadeh
    Mohammadreza Sheikhy-Chaman
    [J]. American Journal of Cardiovascular Drugs, 2023, 23 : 127 - 144
12345